Coronary Artery Disease In Asian Indians: An Update And Review

Enas, Enas A; Senthilkumar, Annamalai
January 2003
Internet Journal of Cardiology;2003, Vol. 2 Issue 1, p12
Academic Journal
Coronary artery disease (CAD) rates vary 10-fold among populations. The CAD rates among overseas Asian Indians worldwide are 50% to 400% higher than people of other ethnic origin irrespective of gender, religion, or social class. India is now in the middle of a CAD epidemic with urban Indians having CAD rates similar to overseas Indians, which is 4-fold higher than Americans. Whereas the CAD rates halved in the West in the past 30 years, the rates doubled in India with no signs of a downturn yet. The average age of first myocardial infarction (MI) has decreased by 20 years in India. Among Asian Indian men, about half of all MI occur under the age of 50 and 25% under the age of 40. Apart from glucose intolerance, they have no excess of conventional risk factors such as cigarette smoking, hypertension, and high cholesterol levels. Nearly half of them are life-long vegetarians. This excess burden of premature CAD in Asian Indians is due to a genetic susceptibility, mediated through elevated levels of lipoprotein(a) {Lp(a)}, which magnifies the adverse effects of lifestyle factors associated with urbanization, affluence, and changes in diet. It appears that at a given level of any single or combination of conventional risk factor(s), the CAD rates among Asian Indians are at least double that of Whites. A more aggressive approach to prevention and treatment of both conventional and emerging risk factors is warranted in the Asian Indians. Although CAD is a fatal disease with no known cure, it is also highly predictable, preventable, and treatable with the existing knowledge.


Related Articles

  • ApoB: Better predictor of CHD?  // Cortlandt Forum;Feb2006, Vol. 19 Issue 2, p15 

    The article reports that apolipoprotein B (AB) and non-high-density lipoprotein cholesterol are better predictors of coronary heart disease (CHD) than low-density lipoprotein (LDL). In a study comparing 243 men who experienced fatal or nonfatal myocardial infarction with 496 matched controls who...

  • Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) study. Kullo, Iftikhar J.; Jouni, Hayan; Olson, Janet E.; Montori, Victor M.; Bailey, Kent R. // BMC Medical Genomics;Aug2015, Vol. 8 Issue 1, p1 

    Background: Whether disclosure of a genetic risk score (GRS) for a common disease influences relevant clinical outcomes is unknown. We describe design of the Myocardial Infarction Genes (MI-GENES) Study, a randomized clinical trial to assess whether disclosing a GRS for coronary heart disease...

  • Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5.  // BMC Genetics;2012, Vol. 13 Issue 1, p12 

    The article offers information on a study conducted on the mapping of a linkage peak with integration of lipid traits, that identifies novel coronary artery disease genes on chromosome 5. It states that with the help of ordered subset analysis (OSA) for dissect genetic heterogeneity and lipid...

  • THE EFFECT OF MYELOPEROXIDASE ON MYOCARDIAL INFARCTION AND SURVIVAL IN APOE/SR-BI KNOCKOUT ANIMALS. Mazhuvanchery, Suzanne B.; Bhat, Nina C.; Brennan, Marie-Luise; Hazen, Stanley L. // Ohio Journal of Science;Mar2008, Vol. 108 Issue 1, pA-28 

    Cardiovascular disease is the leading cause of death in the United States. Research has shown patients who suffered from myocardial infarctions have elevated levels of an enzyme known as yeloperoxidase. Myeloperoxidase is a protein that oxidizes low density lipoprotein (LDL), lipids and other...

  • Intensive statin therapy reduces cardiovascular events.  // Australian Journal of Pharmacy;Mar2011, Vol. 92 Issue 1090, p76 

    The article offers information on the two studies that differentiate intensive statin regimens with placebo and low dose statin therapy on major cardiovascular events. It highlights the significance of low-density lipoprotein (LDL) as triggering factor for coronary heart disease. It notes that...

  • Treatment of Cholesterol Abnormalities. Lockman, Andrew R.; Tribastone, Andrea D.; Knight, Karen V.; Franko, John P. // American Family Physician;3/15/2005, Vol. 71 Issue 6, p1137 

    Cardiovascular disease and its subset coronary heart disease are leading causes of morbidity and mortality in the United States and worldwide. In general, higher levels of low-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease, myocardial infarction,...

  • On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Trabetti, Elisabetta; Biscuola, Michele; Cavallari, Ugo; Malerba, Giovanni; Girelli, Domenico; Olivieri, Oliviero; Martinelli, Nicola; Corrocher, Roberto; Pignatti, Pier Franco // European Journal of Human Genetics;Jan2006, Vol. 14 Issue 1, p127 

    The human oxidised low-density lipoprotein receptor 1 (OLR1) gene is a functional candidate for atherosclerosis. An association of the OLR1 gene with acute myocardial infarction (AMI) or coronary artery disease (CAD) has recently been reported. In the present study a total of 677 Italian...

  • Non-High-Density Lipoprotein. Crawford, Michael H. // Clinical Cardiology Alert;Jan2007, Vol. 26 Issue 1, p7 

    THE PREDICTIVE VALUE ON NON-HIGH-DENSITY lipoprotein (HDL) cholesterol for coronary heart disease (CHD) is unclear. Thus, Liu and colleagues evaluated the original Framingham Cohort Study and the Framingham Offspring Study to assess the contribution of non-HDL cholesterol as compared to...

  • Comparative study of lipid profile in chronic smokers with and without acute myocardial infarction. Kollur, Pampareddy B.; Manjula, R.; Kashinakunti, Sangappa V.; Kallaganada, Gurupadappa S.; Ingin, Jagadish B. // Indian Journal of Public Health Research & Development;Apr-Jun2012, Vol. 3 Issue 2, p110 

    Background: Smoking is one of the major risk factors in the genesis of coronary atherosclerosis and development of coronary heart disease. Smoking may alter normal plasma lipoprotein levels. Objective: The present study was undertaken to compare the lipid profile between chronic smokers (Group...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics